论文部分内容阅读
目的:探讨分析关于肝癌静脉瘘的介入治疗的临床疗效。方法:收集2013年1月至2014年1月在我院接受肝癌静脉瘘介入治疗的患者32例,分析肝癌静脉瘘的介入治疗的方法及临床疗效,观察患者在介入治疗后的治疗效果和并发症的情况。以及肝肿瘤内碘油沉淀、静脉瘘口闭合状况、手术后生存状况和临床病症变化。结果:32例患者肝癌静脉瘘的介入治疗后瘘口闭合良好;患者消化道出血、腹泻、腹水、纳差临床症状减轻;手术后患者生存状态良好,3个月生存率为100%,8个月为81.45%,12个月为78.23%,18个月为72.78%,30个月为24.74%。结论:肝癌静脉瘘的介入治疗后原发性肝癌合并动静脉瘘,采取有效的方法对静脉瘘口进行封闭,临床治疗疗效有明显的提升,并且比较安全,有效的降低了患者并发症的几率,值得临床推广及应用。
Objective: To investigate and analyze the clinical effect of interventional treatment of hepatic venous fistula. Methods: From January 2013 to January 2014 in our hospital received 32 cases of liver cancer fistula interventional treatment of patients with hepatocellular vein fistula interventional analysis of the method and clinical efficacy observed in patients after interventional treatment of the efficacy and concurrent Symptoms of the situation. As well as the hepatic tumor lipiodol deposition, vein fistula closure, postoperative survival and clinical changes. Results: The fistula closed well after the interventional treatment of hepatic vein fistula in 32 patients. The clinical symptoms of patients with gastrointestinal bleeding, diarrhea, ascites and anorexia were relieved. The patients survived well after operation, with 3 months survival rate of 100% and 8 Month was 81.45%, 78.23% in 12 months, 72.78% in 18 months and 24.74% in 30 months. Conclusion: The interventional treatment of hepatocellular carcinoma after primary hepatic cancer complicated with arteriovenous fistula, effective method of closure of the vein fistula, the clinical treatment of significantly improved, and more safe and effective to reduce the risk of patient complications , It is worth clinical promotion and application.